Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13161
Country/Region: Uganda
Year: 2015
Main Partner: Uganda Virus Research Institute
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $581,688 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $8,666
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $1,246
Care: Pediatric Care and Support (PDCS) $1,086
Strategic Information (HVSI) $100,000
Testing: HIV Testing and Counseling (HVCT) $17,409
Sexual Prevention: Other Sexual Prevention (HVOP) $442,110
Treatment: Adult Treatment (HTXS) $10,384
Treatment: Pediatric Treatment (PDTX) $787
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 129
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 13
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 252
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 16
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 410
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 410
CARE_NEW Aggregated Age/sex: <15 Female 2016 13
CARE_NEW Aggregated Age/sex: <15 Male 2016 12
CARE_NEW Aggregated Age/sex: 15+ Female 2016 233
CARE_NEW Aggregated Age/sex: 15+ Male 2016 127
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 385
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 385
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 385
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2016 41
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2016 47
GEND_GBV Number of people receiving post-GBV care 2016 100
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 449
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 339
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 3,434
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,474
HTS_TST By Test Result: Negative 2016 6,428
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 6,696
HTS_TST Sum of Aggregated Age/Sex <15 2016 788
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 5,908
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 6,696
HTS_TST Sum of Test Result disaggregates 2016 6,696
HTS_TST_POS By Test Result: Positive 2016 268
PP_PREV Age/sex: 10-14 Female 2016 181
PP_PREV Age/sex: 10-14 Male 2016 135
PP_PREV Age/sex: 15-19 Female 2016 291
PP_PREV Age/sex: 15-19 Male 2016 238
PP_PREV Age/sex: 20-24 Female 2016 428
PP_PREV Age/sex: 20-24 Male 2016 257
PP_PREV Age/sex: 25-49 Female 2016 621
PP_PREV Age/sex: 25-49 Male 2016 456
PP_PREV Age/sex: 50+ Female 2016 41
PP_PREV Age/sex: 50+ Male 2016 40
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 2,688
PP_PREV Sum of Age/Sex disaggregates 2016 2,688
PP_PREV Total number of people in the target population 2016 6,721
TB_ART Aggregated Age: 15+ 2016 4
TB_ART Female 2016 3
TB_ART Male 2016 1
TB_ART Sum of Aggregated Age disaggregates 2016 4
TB_ART Sum of Sex disaggregates 2016 4
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 5
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 4
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 29
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 381
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 410
TB_SCREEN Sex: Female 2016 268
TB_SCREEN Sex: Male 2016 142
TB_SCREEN Sum of Aggregated Age disaggregates 2016 410
TB_SCREEN Sum of Sex disaggregates 2016 410
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 410
TX_CURR Aggregated Age/Sex: 15+ Female 2016 112
TX_CURR Aggregated Age/Sex: 15+ Male 2016 245
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 385
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 357
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 357
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 102
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 217
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 332
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 319
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 164
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 192
Cross Cutting Budget Categories and Known Amounts Total: $160,000
Gender: Gender Based Violence (GBV) $50,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Gender: Gender Equality $30,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Increase gender-equitable access to income and productive resources, including education
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Key Populations: Sex Workers $80,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention